LOGEX and P95 to jointly build the international infectious disease observatory
Healthcare analytics provider LOGEX and P95, a company specialising in the epidemiology of infectious diseases, have signed an agreement to jointly create an international infectious disease observatory. The goal of the observatory is to offer an international platform for research of infectious diseases like COVID-19, RSV, Influenza, Norovirus and other infections that may have a significant health impact in Europe. Additionally the platform will be used for assessing the impact, effectiveness and safety of vaccines or other pharmaceutical health interventions.
The observatory will initially include 20 hospitals in five European countries. The first proof of concept studies will be presented at the end of 2023. The observatory’s name, ARWEN ID, is derived from the Actionable Real World Evidence Network (ARWEN) and its focus on infectious diseases (IDs).
Follow the progress of this new joint effort on our LinkedIn.
For more information on P95, visit p-95.com
For more information on ARWEN, visit arwen.eu